LLY
1,076.96
+0.06%↑
JNJ
207.49
-0.14%↓
ABBV
230.16
+0.01%↑
UNH
331.59
+1.17%↑
AZN
92.89
+0.42%↑
LLY
1,076.96
+0.06%↑
JNJ
207.49
-0.14%↓
ABBV
230.16
+0.01%↑
UNH
331.59
+1.17%↑
AZN
92.89
+0.42%↑
LLY
1,076.96
+0.06%↑
JNJ
207.49
-0.14%↓
ABBV
230.16
+0.01%↑
UNH
331.59
+1.17%↑
AZN
92.89
+0.42%↑
LLY
1,076.96
+0.06%↑
JNJ
207.49
-0.14%↓
ABBV
230.16
+0.01%↑
UNH
331.59
+1.17%↑
AZN
92.89
+0.42%↑
LLY
1,076.96
+0.06%↑
JNJ
207.49
-0.14%↓
ABBV
230.16
+0.01%↑
UNH
331.59
+1.17%↑
AZN
92.89
+0.42%↑
24h
Corrente
Minimo
3.7
Massimo
3.74
Raccomandazioni | Acquista |
|---|---|
Previsioni per 12 mesi | +187.43% upside |
Utili prossimi | 27 mar 2026 |
|---|
Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.
15 dic 2025, 16:30 UTC
Fortress Biotech Rises After FDA Accepts Application for Menkes Treatment
DJ
LeggI
1 ott 2025, 15:07 UTC
Fortress Biotech Shares Drop After FDA Letter for CUTX-101 Manufacturing Facility
DJ
LeggI
10 mar 2025, 02:12 UTC
Checkpoint Controlling Shareholder Fortress Has Agreed to Vote in Favor of Transaction >524715.BY
DJ
LeggI
10 mar 2025, 02:12 UTC
Sun Pharma, Checkpoint Transaction Expected to Complete in 2Q 2025 >524715.BY
DJ
LeggI
10 mar 2025, 02:11 UTC
Sun Pharma, Checkpoint, Fortress Biotech Enter Into Royalty Agreement >524715.BY
DJ
LeggI
10 mar 2025, 02:11 UTC
Checkpoint Shareholders Entitled to Receive Up to Additional $0.70 if Cosibelimab if Approved in EU Prior to Certain Deadlines >524715.BY
DJ
LeggI
10 mar 2025, 02:10 UTC
Checkpoint Shareholders to Receive Upfront Cash Payment of $4.10/Share, Contingent Value Right >524715.BY
DJ
LeggI
10 mar 2025, 02:10 UTC
Sun Pharma to Acquire Checkpoint Therapeutics >524715.BY CKPT
DJ
LeggI
10 mar 2025, 02:06 UTC
Sun Pharma To Acquire Checkpoint Therapeutics >524715.BY CKPT
DJ
LeggI
Modifica del prezzo
By TipRanks
Previsioni per 12 mesi
Media 10.75 USD 187.43%
Alto 17 USD
Basso 4.5 USD
Basato su 2 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Fortress Biotech Inc - Dist negli ultimi 3 mesi.
By TipRanks
Acquista
2 ratings
2
Acquista
0
Mantieni
0
Vendi
Basato sugli analisti di 2 che hanno fornito valutazioni azionarie a Fortress Biotech Inc - Dist negli ultimi 3 mesi.
$